Knockdown of Ribonucleotide Reductase Regulatory Subunit M2 Increases the Drug Sensitivity of Chronic Myeloid Leukemia to Imatinib‑based Therapy
Oncology Reports - Greece
doi 10.3892/or.2019.7194
Full Text
Open PDFAbstract
Available in full text
Date
June 11, 2019
Authors
Publisher
Spandidos Publications